PT  - JOURNAL ARTICLE
AU  - Rouy, Martin
AU  - Roger, Matthieu
AU  - Goueytes, Dorian
AU  - Pereira, Michael
AU  - Roux, Paul
AU  - Faivre, Nathan
TI  - Preserved electrophysiological markers of confidence in schizophrenia spectrum disorder
AID  - 10.1101/2022.10.19.22281249
DP  - 2022 Jan 01
TA  - medRxiv
PG  - 2022.10.19.22281249
4099  - http://medrxiv.org/content/early/2022/10/21/2022.10.19.22281249.short
4100  - http://medrxiv.org/content/early/2022/10/21/2022.10.19.22281249.full
AB  - A large number of behavioral studies suggest that confidence judgments are impaired in schizophrenia, motivating the search for neural correlates of an underlying metacognitive impairment. Electrophysiological studies suggested that a specific evoked response potential reflecting performance monitoring, namely the error-related negativity (ERN), was blunted in schizophrenia compared to healthy controls. However, attention has recently been drawn to a potential confound in the study of metacognition, namely that lower first-order performance in schizophrenia compared to healthy controls could lead to a spurious decrease in metacognitive performance among patients. Here, we assessed how this confound might also apply to ERN-blunting in schizophrenia. We used an adaptive staircase procedure to titrate first-order performance on a motion discrimination task in which participants (N = 14 patients and 19 controls) had to report their confidence after each trial while we recorded high density EEG. Interestingly, not only metaperceptual abilities were preserved among patients at the behavioral level, but we also found no electrophysiological evidence for altered EEG markers of performance monitoring. These results bring additional evidence suggesting an unaltered ability to monitor perceptual performance on a trial by trial basis in schizophrenia.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialNCT03140475Funding StatementERC 803122Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study was approved by the ethical committee Sud Mediterannee II (217 R01). I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll analysis scripts and behavioral data are publicly available (https://gitlab.com/nfaivre/meta_scz_public). All EEG data will be available upon publication. https://gitlab.com/nfaivre/meta_scz_public